Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Canopy GrowthSTADA Arzneimittel AktiengesellschaftAphriaTilrayCronos Group
SymbolNASDAQ:CGCOTCMKTS:STDAFNASDAQ:APHANASDAQ:TLRYNASDAQ:CRON
Price Information
Current Price$28.99$110.42$16.28$19.76$8.88
52 Week RangeHoldN/ABuyHoldHold
MarketRank™
Overall Score0.80.41.71.00.8
Analysis Score3.00.04.32.00.9
Community Score1.22.03.42.32.3
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.00.60.60.6
Analyst Ratings
Consensus RecommendationHoldN/ABuyHoldHold
Consensus Price Target$35.68N/A$21.14$18.31$8.50
% Upside from Price Target23.07% upsideN/A29.87% upside-7.35% downside-4.28% downside
Trade Information
Market Cap$11.08 billion$6.88 billion$5.16 billion$3.39 billion$3.20 billion
Beta2.440.542.673.122.07
Average Volume6,639,79218023,791,14139,321,6096,129,464
Sales & Book Value
Annual Revenue$297.34 million$2.92 billion$405.96 million$166.98 million$25.64 million
Price / Sales37.262.3612.7020.33124.77
Cashflow$1.37 per share$11.26 per share$0.10 per shareN/A$0.60 per share
Price / Cash21.169.81166.43N/A14.76
Book Value$10.97 per share$21.48 per share$4.80 per share$2.78 per share$5.01 per share
Price / Book2.645.143.397.111.77
Profitability
Net Income$-993,370,000.00$339.02 million$-63,210,000.00$-321,170,000.00$1.17 billion
EPS$1.32N/A($0.06)($1.69)$0.67
Trailing P/E RatioN/A0.00N/AN/A37.00
Forward P/E RatioN/A232.57N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-312.84%N/A-36.10%-242.60%266.31%
Return on Equity (ROE)-13.11%N/A-2.30%-92.70%-1.61%
Return on Assets (ROA)-9.66%N/A-1.66%-20.70%-1.41%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.10%2.26%0.25%2.75%N/A
Current Ratio7.06%1.49%2.36%2.28%9.75%
Quick Ratio5.84%0.93%1.17%1.61%9.36%
Ownership Information
Institutional Ownership Percentage10.18%N/A10.30%12.62%11.75%
Insider Ownership Percentage0.26%N/AN/A16.75%7.93%
Miscellaneous
Employees4,43411,1001,2001,646631
Shares Outstanding382.16 million62.34 million316.80 million171.76 million360.26 million
Next Earnings Date6/4/2021 (Estimated)N/A4/12/2021 (Confirmed)5/10/2021 (Estimated)5/14/2021 (Estimated)
OptionableOptionableNot OptionableOptionableOptionableOptionable
SourceHeadline
This Surprising Projection Shows Why Big Tobacco Is Moving Into CannabisThis Surprising Projection Shows Why Big Tobacco Is Moving Into Cannabis
msn.com - April 6 at 6:24 AM
Cronos Group Stock Is Estimated To Be Possible Value TrapCronos Group Stock Is Estimated To Be Possible Value Trap
finance.yahoo.com - March 30 at 4:49 AM
Cronus Group Stock is Cash Rich Cannabis PlayCronus Group Stock is Cash Rich Cannabis Play
marketbeat.com - March 29 at 9:57 AM
Cronos Group Inc. (NASDAQ:CRON) Is an Exciting StockCronos Group Inc. (NASDAQ:CRON) Is an Exciting Stock
stocksregister.com - March 27 at 2:50 AM
Altria Group, Inc. Director and Chairman of the Board of Directors Thomas F. Farrell II Announces Decision to Retire From Altria’s Board of DirectorsAltria Group, Inc. Director and Chairman of the Board of Directors Thomas F. Farrell II Announces Decision to Retire From Altria’s Board of Directors
businesswire.com - March 23 at 5:40 PM
Stocks End Week on Slight Up NoteStocks End Week on Slight Up Note
ca.finance.yahoo.com - March 19 at 6:02 PM
CRON April 30th Options Begin TradingCRON April 30th Options Begin Trading
nasdaq.com - March 13 at 3:18 AM
5 Surprising Numbers From Cronos Q4 Earnings Report5 Surprising Numbers From Cronos' Q4 Earnings Report
finance.yahoo.com - March 9 at 8:42 AM
Cronos Group: Slow LaunchCronos Group: Slow Launch
seekingalpha.com - March 1 at 6:07 PM
Cronos Group Inc. (CRON) CEO Kurt Schmidt on Q4 2020 Results - Earnings Call TranscriptCronos Group Inc. (CRON) CEO Kurt Schmidt on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 28 at 6:56 AM
Cronos Group Inc. (CRON) Reports 2020 Fourth Quarter and Full-Year ResultsCronos Group Inc. (CRON) Reports 2020 Fourth Quarter and Full-Year Results
marketwatch.com - February 27 at 1:34 AM
Cronos Group Inc. (CRON) Q4 2020 Earnings Call TranscriptCronos Group Inc. (CRON) Q4 2020 Earnings Call Transcript
fool.com - February 26 at 9:36 PM
Cannabis Stocks Skid On Cronos Earnings, But Industry Poised For GrowthCannabis Stocks Skid On Cronos Earnings, But Industry Poised For Growth
forbes.com - February 26 at 8:33 PM
Cronos Group Slides on Q4 ResultsCronos Group Slides on Q4 Results
finance.yahoo.com - February 26 at 8:33 PM
Cronos Stock Pulls Back After Earnings, It Might Be Time To Buy SomeCronos Stock Pulls Back After Earnings, It Might Be Time To Buy Some
marketbeat.com - February 26 at 4:18 PM
Cronos Group (CRON) Reports Q4 Loss, Tops Revenue EstimatesCronos Group (CRON) Reports Q4 Loss, Tops Revenue Estimates
nasdaq.com - February 26 at 3:33 PM
Cronos Drops After Cannabis Firm Swings to Quarterly LossCronos Drops After Cannabis Firm Swings to Quarterly Loss
msn.com - February 26 at 10:24 AM
Cronos Group Q4 Revenue Increases 133% to $17 Million with Adjusted EBITDA Loss of $53 millionCronos Group Q4 Revenue Increases 133% to $17 Million with Adjusted EBITDA Loss of $53 million
newcannabisventures.com - February 26 at 10:24 AM
Wall Street Analysts Advise Selling These 2 Cannabis StocksWall Street Analysts Advise Selling These 2 Cannabis Stocks
stocknews.com - February 24 at 2:54 PM
Cronos Group and Other Cannabis Stocks Could See Higher HighsCronos Group and Other Cannabis Stocks Could See Higher Highs
feedproxy.google.com - February 23 at 2:30 PM
TSX rises 0.2% to 18,422.24TSX rises 0.2% to 18,422.24
msn.com - February 22 at 8:30 PM
Stay Away from These 4 Overvalued Marijuana StocksStay Away from These 4 Overvalued Marijuana Stocks
stocknews.com - February 22 at 3:30 PM
Interesting CRON Put And Call Options For April 1stInteresting CRON Put And Call Options For April 1st
nasdaq.com - February 13 at 5:41 PM
Cannabis Stocks Felt the Reddit Rumble This WeekCannabis Stocks Felt the Reddit Rumble This Week
schaeffersresearch.com - February 12 at 3:12 PM
IIROC Trading Halt - CRONIIROC Trading Halt - CRON
finance.yahoo.com - February 12 at 3:12 PM
IIROC Trade Resumption - CRONIIROC Trade Resumption - CRON
finance.yahoo.com - February 12 at 3:12 PM
Enveric Biosciences Inc. Announces Closing of $12.8 Million Registered Direct Offering of Common StockEnveric Biosciences Inc. Announces Closing of $12.8 Million Registered Direct Offering of Common Stock
lelezard.com - February 12 at 10:08 AM
DateCompanyBrokerageAction
4/9/2021Canopy GrowthCantor FitzgeraldLower Price Target
4/8/2021Canopy GrowthAlliance Global PartnersLower Price Target
4/5/2021Canopy GrowthCIBCLower Price Target
2/24/2021Canopy GrowthJefferies Financial GroupDowngrade
2/11/2021Canopy GrowthDesjardinsBoost Price Target
2/10/2021Canopy GrowthCormarkDowngrade
2/10/2021Canopy GrowthBMO Capital MarketsReiterated Rating
2/10/2021Canopy GrowthBenchmarkDowngrade
2/10/2021Canopy GrowthCanaccord GenuityDowngrade
2/5/2021Canopy GrowthPiper SandlerDowngrade
2/4/2021Canopy GrowthStifel NicolausReiterated Rating
9/4/2020Canopy GrowthCfraUpgrade
8/21/2020Canopy GrowthOppenheimerReiterated Rating
6/1/2020Canopy GrowthScotiabankBoost Price Target
6/1/2020Canopy GrowthLADENBURG THALM/SH SHDowngrade
7/30/2020AphriaPi FinancialReiterated Rating
2/18/2021TilrayRoth CapitalBoost Price Target
10/1/2020TilrayMKM PartnersLower Price Target
8/11/2020TilrayNorthland SecuritiesReiterated Rating
3/1/2021Cronos GroupRaymond JamesSet Price Target
4/2/2020Cronos GroupBank of AmericaDowngrade
(Data available from 4/11/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.